Novo Nordisk
NVO
#22
Rank
HK$3.078 T
Marketcap
HK$660.45
Share price
-17.83%
Change (1 day)
-18.27%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2024 (TTM): HK$139.24 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are HK$39.69 Billion. In 2023 the company made an earning of HK$119.88 Billion, an increase over its 2022 earnings that were of HK$76.05 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) HK$139.24 B16.15%
2023 HK$119.88 B57.64%
2022 HK$76.05 B5.35%
2021 HK$72.19 B12.47%
2020 HK$64.18 B13.07%
2019 HK$56.76 B-3.35%
2018 HK$58.73 B1.79%
2017 HK$57.69 B4.52%
2016 HK$55.20 B9.42%
2015 HK$50.45 B8.24%
2014 HK$46.61 B3.45%
2013 HK$45.05 B19.02%
2012 HK$37.85 B15.21%
2011 HK$32.86 B17.71%
2010 HK$27.91 B24.78%
2009 HK$22.37 B10.62%
2008 HK$20.22 B55.97%
2007 HK$12.96 B7.07%
2006 HK$12.11 B18.18%
2005 HK$10.24 B11.33%
2004 HK$9.20 B
2002 HK$5.73 B-14.39%
2001 HK$6.70 B-52.82%
2000 HK$14.20 B250%
1999 HK$4.05 B31.21%
1998 HK$3.09 B34.31%
1997 HK$2.30 B11.46%
1996 HK$2.06 B9.03%
1995 HK$1.89 B-3.15%
1994 HK$1.95 B-0.67%
1993 HK$1.96 B45.38%
1992 HK$1.35 B-13.81%
1991 HK$1.57 B37.12%
1990 HK$1.14 B-0.79%
1989 HK$1.15 B26.2%
1988 HK$0.91 B24.97%
1987 HK$0.73 B-0.9%
1986 HK$0.73 B-7.78%
1985 HK$0.80 B24.87%
1984 HK$0.64 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
HK$53.94 B-61.09%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$78.86 B-43.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$53.46 Billion-138.56%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$57.55 B-58.48%๐Ÿ‡ซ๐Ÿ‡ท France